Association for Molecular Pathology
 

Mark Your Calendars!
Presented by the AMP Training & Education Committee
JAK2 and MPL Mutation Testing in Myeloproliferative Neoplasms
January 13, 2009, 1:00pm (ET)

Host: Charles E. Hill, MD, PhD
Emory University School of
Medicine, Atlanta, GA (USA)
 
Speaker: Jonathan M. Diver, PhD
VP of Applications Development
and Molecular Laboratory
Genoptix, Inc., Carlsbad, CA (USA)

Topics of Discussion
Structure and biological function of the JAK2 and MPL proteins in regulation of normal hematopoiesis
Clinical and pathological presentation of MPNs highlighting the role of molecular testing for JAK2 and    MPL mutations as an aid to diagnosis
Molecular assay design options and appropriate controls  with consideration of sensitivity, quantitation, throughput, and reagent cost.

   
   

 



 

 

Letter sent to the WHO endorsing reference materials for fragile X and other molecular tests.

New Position Statement: Gene Patents and the Exclusive Licensing of Genetic Discoveries


The Clinical Practice Committee has released a catalogue of mutation database websites.

October Newsletter

CMS has announced that it will publish most of the edits used in its MUE program on its website.

AMP members Vicky Pratt, Terry Dunn and Karen Weck contribute article for Update magazine.
>> Click here to read the article

Victor Almon McKusick, M.D. (1921-2008)

We are saddened by the recent death of Dr. Victor McKusick.
>> Read More...


May Newsletter

AMP provides comments to FDA, NIGMS and the SACGHS.

AMP continues to support the Genetic Information Nondiscrimination Act (GINA)

February Newsletter

Comments to the SACGHS Task Force Draft Report Regarding Oversight of Genetic Testing

>>News Archive

 

The Journal of Molecular Diagnostics
>> General Information

>> JMD Online
(Non-Member Access)


>> Position Available: Editor-in-Chief




AMP Test Directory

AMP Leadership Fund


Collaboration Opportunities
 


 

 




12/29/2008